Border to Coast Pensions Partnership Ltd Lowers Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Border to Coast Pensions Partnership Ltd lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 141,639 shares of the healthcare conglomerate's stock after selling 18,363 shares during the quarter. UnitedHealth Group accounts for about 1.5% of Border to Coast Pensions Partnership Ltd's investment portfolio, making the stock its 17th largest position. Border to Coast Pensions Partnership Ltd's holdings in UnitedHealth Group were worth $74,183,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of UNH. Illinois Municipal Retirement Fund increased its stake in UnitedHealth Group by 1.6% in the 1st quarter. Illinois Municipal Retirement Fund now owns 58,093 shares of the healthcare conglomerate's stock worth $30,426,000 after buying an additional 936 shares in the last quarter. Trust Co. of Vermont grew its position in shares of UnitedHealth Group by 1.4% during the first quarter. Trust Co. of Vermont now owns 39,544 shares of the healthcare conglomerate's stock worth $20,711,000 after purchasing an additional 551 shares in the last quarter. Victrix Investment Advisors lifted its holdings in UnitedHealth Group by 4.9% in the 1st quarter. Victrix Investment Advisors now owns 5,575 shares of the healthcare conglomerate's stock worth $2,819,000 after purchasing an additional 259 shares in the last quarter. Park Place Capital Corp grew its holdings in UnitedHealth Group by 32.0% during the 1st quarter. Park Place Capital Corp now owns 5,824 shares of the healthcare conglomerate's stock valued at $3,050,000 after buying an additional 1,411 shares in the last quarter. Finally, Beacon Financial Advisory LLC bought a new position in shares of UnitedHealth Group during the first quarter worth $204,000. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the topic of several research analyst reports. JPMorgan Chase & Co. boosted their price target on shares of UnitedHealth Group from $405.00 to $418.00 and gave the stock an "overweight" rating in a research note on Friday, June 20th. Wells Fargo & Company restated an "overweight" rating on shares of UnitedHealth Group in a report on Friday, June 6th. Barclays lowered their target price on UnitedHealth Group to $350.00 and set an "overweight" rating for the company in a research report on Monday, June 2nd. Mizuho decreased their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Finally, Raymond James Financial downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $415.57.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer now owns 10,398 shares of the company's stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Stephen J. Hemsley purchased 86,700 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer now directly owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Performance

UNH opened at $302.43 on Friday. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $274.35 billion, a PE ratio of 12.66, a PEG ratio of 1.43 and a beta of 0.44. The firm's 50-day moving average price is $339.15 and its 200 day moving average price is $456.28.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.92%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is currently 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.